GENTAMICIN

Pre-Launch

gentamicin sulfate

Medica Corp

ANDAINJECTIONINJECTABLE

Lifecycle

Pre-Launch

Clinical Trials

Data completeness

3/8 — Basic

GENTAMICIN (gentamicin sulfate) by Medica Corp is clinical pharmacology gentamicin sulfate is a wide spectrum antibiotic that provides highly effective topical treatment in primary and secondary bacterial infections of the skin. Approved for psoriasis.

Drug data last refreshed 1mo ago

Mechanism of Action

CLINICAL PHARMACOLOGY Gentamicin sulfate is a wide spectrum antibiotic that provides highly effective topical treatment in primary and secondary bacterial infections of the skin. Gentamicin Sulfate Cream may clear infections that have not responded to treatment with other topical antibiotic agents.…

Indications (1)

psoriasis

Clinical Trials (2)

NCT07270380N/ANot Yet Recruiting

Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin.

Started Apr 2026

139 enrolled

Osteomyelitis

NCT03503513Phase 2/3Completed

Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury

Started Aug 2018

23 enrolled

Urinary Tract InfectionsSpinal Cord InjuriesSpinal Cord Diseases+1 more

Worked on GENTAMICIN at Medica Corp? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.